Centinel Spine’s Prodisc C Vivo and Prodisc C Nova earned the European Union’s Medical Device Regulation certifications, according to a Sept. 11 news release.
Prodisc C Vivo and C Nova are the only cervical total disc replacement systems with two different MDR-certified devices. They have been used in clinical use internationally since 2009.
“This marks a pivotal moment for Centinel Spine as an organization,” Steve Murray, Centinel Spine’s CEO, said in the release. “Securing MDR certification for the prodisc C Vivo and prodisc C Nova total disc replacement devices has been a complex and demanding process, but it underscores our commitment to delivering safe, high-quality, and clinically-proven products. A fundamental pillar of our strategic vision is to improve the lives of as many patients as possible worldwide by expanding access to prodisc technologies.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
